Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00725101 · ClinicalTrials.gov registry record
Fibromyalgia Health Outcome Study on Cost of Treatments
A clinical trial, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 1,700
- Enrollment target
NCT00725101 is a clinical trial that has completed, run by Eli Lilly and Company. The registered enrollment target is 1,700 participants.
The verdict
NCT00725101 has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 1,700 participants
- Enrollment target
Study Summary
The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to examine treatment patterns and health outcomes of adult participants diagnosed by their physician with fibromyalgia (FM) and who are starting any "new pharmacologic agent" for FM. The primary benefit of this study is enhanced understanding of the disease state of FM and the role that pharmacologic treatment plays, which may help to optimize management of FM. This study will address current gaps in a rapidly growing body of literature on FM.
Interventions
- DRUG Treatment for Fibromyalgia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,700 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00725101
The ClinicalTrials.gov registry entry for NCT00725101 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment for Fibromyalgia is the first listed.
NCT00725101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00725101 about?
NCT00725101 is a clinical study titled "Fibromyalgia Health Outcome Study on Cost of Treatments". The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to examine treatment patter...
What is the current status of trial NCT00725101?
This trial is currently completed. The enrollment target is 1,700 participants. The study started on 2008-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00725101?
The interventions under investigation include: Treatment for Fibromyalgia (DRUG).
Who is sponsoring clinical trial NCT00725101?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.